Drugs / Anshen Buxin Liuwei Pill

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04932395 Jun 2021 → Dec 2023 neurocirculatory asthenia China Academy of Chinese Medical Sciences Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Anshen Buxin Liuwei Pill ClinicalTrials.gov intervention name — accepted as the source's own label NCT04932395 ↗
Modality Traditional medicine (herbal / TCM) “traditional Mongolian medicine Anshen Buxin Liuwei Pill” NCT04932395 ↗
Route Oral “15 capsules/time, 2 times/day, orally” NCT04932395 ↗